Science & Education

Cannabis and Your Heart: What the Cardiovascular Research Shows

By RethinkTHC Research Team|15 min read|February 24, 2026

Science & Education

34%

A 2025 JAMA study found daily cannabis users face a 34 percent higher risk of coronary artery disease, with a dose-response pattern where more frequent use meant greater cardiovascular risk.

Malvi et al., JAMA, 2025

Malvi et al., JAMA, 2025

Infographic showing 2025 JAMA study linking daily cannabis use to 34 percent higher coronary artery disease riskView as image

You have been using cannabis for a while. Maybe daily, maybe most days. And somewhere along the way you came across a headline connecting weed to heart disease. Now you are trying to figure out how worried you should actually be. That is a reasonable question, and the honest answer requires looking at what the emerging research says about cannabis heart cardiovascular risk, rather than relying on fear-based headlines or blanket reassurances.

The science here has shifted meaningfully in the last few years. A broad overview of cannabis and cardiovascular health shows that the earlier research was genuinely mixed. But newer, larger studies are sharpening the picture, particularly around daily use. This article breaks down the latest findings, explains the biological mechanisms, and helps you understand what this means for your specific situation.

Key Takeaways

  • A 2025 study in JAMA found that daily cannabis users had a 34% higher risk of developing coronary artery disease compared to non-users
  • CB1 receptors are present directly in heart tissue, which means THC acts on the heart itself — not just indirectly through your nervous system
  • Smoking cannabis carries the highest cardiovascular risk of any method because burning plant matter produces carbon monoxide, fine particles, and oxidative stress that directly damage your artery walls
  • The risk appears to be age-dependent — adults over 45 face significantly greater cardiovascular risk than younger users, partly because hidden heart disease becomes more common with age
  • The cannabis-heart connection is real but still much smaller than the established link between tobacco and heart disease
  • The 2025 JAMA study found a dose-response pattern where more frequent cannabis use meant higher cardiovascular risk — one of the key signals researchers look for when deciding whether an association might be causal

The 2025 JAMA Study: Daily Use and Heart Disease Risk

Science & Education

Cannabis & Your Heart: Risk by Route and Age

Smoking (combustion)Risk: Highest

Carbon monoxide + fine particles + oxidative stress damage artery walls directly

VapingRisk: Lower than smoking

Fewer combustion byproducts, but still delivers THC cardiovascular effects

EdiblesRisk: Lowest route-specific

No respiratory toxicants; still delivers THC to CB1 receptors in heart tissue

Risk by age group:
Under 35Low (if healthy)Most cardiac events in young users are stress-related, not structural
35–45ModerateHidden heart disease begins; daily use raises baseline risk
45+ElevatedPre-existing conditions more likely; THC adds to existing cardiovascular burden

Perspective: The 2025 JAMA study found 34% higher CAD risk with daily use — real but still much smaller than tobacco's cardiovascular impact. Dose-response pattern (more use = more risk) strengthens the causal case.

Source: JAMA (2025); AHA Scientific StatementCannabis & Your Heart: Risk by Route and Age

The most significant recent development came from a large population-based study published in JAMA in 2025. Researchers analyzed data from hundreds of thousands of participants and found that daily cannabis users had a 34% higher risk of developing coronary artery disease compared to people who did not use cannabis.

A 34% increase sounds alarming. But context matters. This was an observational study, meaning researchers tracked patterns in existing data rather than randomly assigning people to use cannabis. Observational studies can identify strong associations, but they cannot prove that cannabis directly caused the heart disease. Confounding factors (other variables that differ between cannabis users and non-users, like diet, stress, tobacco co-use, and healthcare access) are always part of the picture.

That said, this study was large and well-designed, and it controlled for many of the common confounders. The finding was statistically significant, meaning the association was strong enough that it was unlikely to be explained by chance alone. And it aligns with a pattern emerging across several recent studies: occasional use does not appear to carry meaningful cardiovascular risk, but heavy, daily use does seem to matter.

The JAMA study also found a dose-response relationship. More frequent use was associated with higher risk. This is one of the signals researchers look for when trying to determine whether an association might be causal. When increasing exposure leads to increasing risk in a consistent pattern, it strengthens the case that the exposure is playing a real role.

How THC Acts on Your Heart: The CB1 Receptor Mechanism

Understanding why cannabis might affect heart health starts with the biology. Your heart is not a passive bystander when you consume THC. It is an active participant.

CB1 receptors (the primary docking stations that THC binds to) are present throughout your cardiovascular system, including directly in cardiac muscle tissue and in the walls of blood vessels. When THC activates these receptors, several things happen simultaneously.

First, your sympathetic nervous system fires up (the fight-or-flight response). Heart rate increases, typically by 20 to 50 beats per minute. Blood pressure shifts. For most people, this is a temporary spike that resolves within a few hours.

Second, and more relevant to long-term risk, THC-driven CB1 activation in arterial walls appears to promote endothelial dysfunction (impaired function of the cells lining your blood vessels). Healthy endothelial cells keep blood flowing smoothly and resist plaque buildup. When endothelial function degrades, arteries become more vulnerable to inflammation and the early stages of atherosclerosis (the gradual hardening and narrowing of arteries that underlies most heart disease).

Third, emerging animal research suggests that chronic CB1 activation may promote arterial inflammation directly. Inflammation in blood vessel walls is one of the key drivers of cardiovascular disease. This mechanism is still being studied in humans, but it offers a biologically plausible explanation for the associations showing up in population data.

The acute effect (temporary tachycardia, or rapid heartbeat) is well established and something most cannabis users have noticed firsthand. If you have ever felt your heart racing after using cannabis, that is CB1 activation in your sympathetic nervous system. For healthy, younger users, the heart handles this without issue. But repeated daily cycles of cardiovascular stress, combined with potential arterial inflammation, may accumulate over years. This is likely what the JAMA data is capturing.

Why Smoking Is the Highest-Risk Route

Not all cannabis consumption methods carry the same cardiovascular risk. Smoking is the worst option for your heart, and it is not close.

When you combust cannabis, you inhale carbon monoxide, which reduces the oxygen-carrying capacity of your blood. Your heart has to work harder to deliver the same amount of oxygen to your tissues. You also inhale fine particulate matter that penetrates deep into lung tissue and enters the bloodstream, where it triggers inflammatory responses in arterial walls.

These combustion byproducts damage blood vessels through the same mechanisms that make tobacco smoking so harmful to cardiovascular health. The key difference is dose: most cannabis smokers consume fewer total sessions per day than cigarette smokers. But per session, the particulate exposure from a joint can be comparable to or higher than a cigarette, partly because cannabis smokers tend to inhale more deeply and hold the smoke longer.

For anyone concerned about cardiovascular risk, switching to a non-combustion method (edibles, tinctures, or dry herb vaporizers) removes the combustion-specific harms entirely. The THC-related effects on heart rate and CB1 activation remain, but the carbon monoxide and particulate exposure disappear. If you want to learn more about what happens to your lungs when you stop smoking, the research on lung recovery after quitting is encouraging.

Cannabis vs. Tobacco: Putting the Risk in Perspective

A natural question when hearing about cannabis and heart risk is: how does it compare to tobacco?

Tobacco smoking is the single largest preventable cause of cardiovascular disease worldwide. It roughly doubles to quadruples the risk of coronary heart disease. The cannabis association found in the JAMA study (a 34% increase with daily use) is real but significantly smaller in magnitude.

This does not mean cannabis cardiovascular risk should be dismissed. A 34% increased risk, if confirmed as causal, is clinically meaningful, particularly for people who already carry other risk factors. But it does mean the two substances are not equivalent threats to your heart. The common framing of "weed is just as bad as cigarettes for your heart" is not supported by the current data.

Where the comparison gets more complicated is when people smoke both. Many cannabis users also use tobacco, either separately or in combination (spliffs, blunts). In those cases, the cardiovascular risks are additive and potentially synergistic. Separating the independent contribution of each substance is one of the biggest challenges in this research.

Age-Dependent Risk: Why It Matters More After 45

Cannabis cardiovascular risk is not evenly distributed across age groups. The data consistently shows that older adults face significantly greater risk than younger users.

There are several reasons for this. By age 45, many people have subclinical atherosclerosis (early plaque buildup in arteries that has not yet caused symptoms or been diagnosed). When cannabis triggers acute cardiovascular stress on top of already-compromised arteries, the margin for error shrinks. A 25-year-old with clean, flexible arteries can absorb a temporary heart rate spike without consequence. A 55-year-old with undetected coronary narrowing may not have the same reserve.

The growing population of older cannabis users makes this especially relevant. Many adults in their 50s and 60s are returning to cannabis after decades away, or trying it for the first time for pain management or sleep. Understanding what the medical research actually shows helps these users make informed decisions rather than relying on assumptions from a different era.

If you are over 45 and using cannabis regularly, a baseline cardiovascular evaluation is a reasonable step. Knowing your blood pressure, cholesterol levels, and overall cardiac status lets you weigh the risks based on your actual health profile rather than general population statistics.

Pre-Existing Heart Conditions: What You Need to Know

For people with diagnosed cardiovascular conditions (coronary artery disease, history of heart attack, heart failure, arrhythmias), the calculus around cannabis use is different than for healthy individuals.

The acute effects of THC (increased heart rate, blood pressure shifts, increased cardiac workload) place additional strain on a heart that is already working harder than it should be. If you have experienced chest tightness or heart palpitations related to cannabis, those symptoms deserve attention rather than dismissal.

This does not mean everyone with a heart condition must avoid cannabis entirely. But it does mean the decision should involve your cardiologist, honest disclosure about how much and how often you use, and awareness that the risk-benefit ratio looks different for you than for someone without cardiovascular disease.

What the Research Still Cannot Tell Us

Honesty about the limits of current knowledge matters. Several critical questions remain unanswered.

We do not know whether the association between daily cannabis use and heart disease is fully causal or partly explained by unmeasured confounders. We do not know whether edibles and vaporizers carry the same long-term cardiovascular risk as smoking, because most studies have not separated consumption methods. We do not know how increasing THC potency over time affects cardiovascular outcomes, since most large-scale studies cover periods when lower-potency products were the norm.

We also lack long-term prospective data (studies that follow the same people for decades) specifically designed to isolate cannabis cardiovascular effects. The research is getting better and more specific every year, but the honest summary is that we are in a period of emerging evidence, not settled conclusions.

When to Seek Professional Help

If you experience chest pain, pressure, or tightness during or after cannabis use, do not wait it out. Seek medical evaluation. The same applies to sudden shortness of breath, heart palpitations that feel different from your usual experience, dizziness with near-fainting, or any symptoms that come on one side of the body (which could indicate stroke).

If you are using cannabis daily and want to reduce your use but find it difficult, that is a common experience with well-understood solutions. Your doctor can help you create a plan, and support does not require any specific label or commitment beyond wanting to make a change.

SAMHSA's National Helpline is available at 1-800-662-4357. It is free, confidential, and available 24 hours a day, 7 days a week.

The Bigger Picture

The emerging cardiovascular research on cannabis is not a reason to panic, but it is a reason to pay attention. The evidence increasingly suggests that daily, long-term use, particularly through smoking, carries meaningful cardiovascular risk that grows with age and pre-existing conditions.

You get to decide what to do with this information. For some people, it will mean switching consumption methods. For others, reducing frequency. For others still, it will simply mean getting a cardiac checkup and making an informed choice to continue. All of those are legitimate responses. What matters is that the decision is yours, based on the actual science rather than either alarmism or denial.

The Bottom Line

A 2025 JAMA study found daily cannabis users had a 34% higher risk of developing coronary artery disease compared to non-users, with a dose-response relationship (more frequent use = higher risk). The biological mechanism involves CB1 receptors present directly in cardiac tissue and arterial walls: THC activation increases heart rate by 20-50 bpm (sympathetic nervous system activation), promotes endothelial dysfunction (impaired blood vessel lining that increases vulnerability to plaque buildup), and may drive arterial inflammation (a key driver of cardiovascular disease). Smoking is the highest-risk consumption method because combustion produces carbon monoxide (reduces blood oxygen, forces heart to work harder), fine particulate matter (triggers arterial wall inflammation), and oxidative stress — per-session particulate exposure from a joint can match or exceed a cigarette due to deeper inhalation. Non-combustion methods (edibles, tinctures, dry herb vaporizers) eliminate combustion-specific harms while retaining THC-related effects. Cannabis cardiovascular risk is age-dependent: adults over 45 face significantly greater risk because subclinical atherosclerosis reduces the heart's reserve capacity for THC-induced stress. In perspective: tobacco doubles to quadruples coronary heart disease risk vs. the 34% increase from daily cannabis use — the two are not equivalent cardiovascular threats. Study limitations: observational design cannot prove causation, most studies have not separated consumption methods, and increasing THC potency effects on cardiovascular outcomes are not yet studied.

Frequently Asked Questions

Sources & References

  1. 1RTHC-08584·Ritson, Megan et al. (2026). Cannabis, Cocaine, and Amphetamines All Linked to Higher Stroke Risk in Major Analysis.” International journal of stroke : official journal of the International Stroke Society.Study breakdown →PubMed →
  2. 2RTHC-06232·Chye, David M et al. (2025). Cannabis use was associated with a 71% increased risk of atrial arrhythmias.” Heart rhythm.Study breakdown →PubMed →
  3. 3RTHC-07035·Malvi, Ajay et al. (2025). Cannabis Users Had 31% Higher Odds of Having Asthma in a Meta-Analysis.” BMC pulmonary medicine.Study breakdown →PubMed →
  4. 4RTHC-05781·Velayudhan, Latha et al. (2024). Cannabinoid Medicines Are Generally Safe for Older Adults, With Dose-Dependent Side Effects.” Age and ageing.Study breakdown →PubMed →
  5. 5RTHC-04980·Theerasuwipakorn, Nonthikorn (2023). Cannabis and Heart Attack/Stroke Risk: A 183-Million-Patient Meta-Analysis Finds Stroke Risk but Not Heart Attack Risk.” Toxicology Reports.Study breakdown →PubMed →
  6. 6RTHC-02633·Johnson, Emma C et al. (2020). Largest genetic study of cannabis use disorder identifies 22 risk genes.” The lancet. Psychiatry.Study breakdown →PubMed →
  7. 7RTHC-01765·Minică, Camelia C et al. (2018). A genome-wide study of nearly 25,000 people found age of first cannabis use is 38% heritable with a suggestive genetic link to calcium signaling.” Addiction (Abingdon.Study breakdown →PubMed →
  8. 8RTHC-01785·Pasman, Joëlle A et al. (2018). The largest GWAS of cannabis use identified 8 genetic variants, found 11% heritability, and showed schizophrenia risk causally influences cannabis use.” Nature neuroscience.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong EvidenceMeta-Analysis

Does Illicit Drug Use Increase Stroke Risk? A Systematic review, Meta-Analyses and Mendelian Randomization analysis.

Ritson, Megan · 2026

Meta-analysis of 32 studies (>100 million participants) found cannabis associated with 37% higher stroke risk (OR 1.37), cocaine with 96% higher risk (OR 1.96), and amphetamines with 122% higher risk (OR 2.22).

Strong EvidenceMeta-Analysis

Cannabis use and atrial arrhythmias: A systematic review and meta-analysis of large populational studies.

Chye, David M · 2025

Cannabis associated with 71% increased atrial arrhythmia risk (OR 1.71, 95% CI 1.1-2.6); risk higher with concomitant drug use (OR 1.91) and in cannabis-legal countries (OR 1.93); 12.5% of cannabis users had AA vs 2.7% of controls..

Strong EvidenceMeta-Analysis

Cannabis consumption and risk of asthma: a systematic review and meta-analysis.

Malvi, Ajay · 2025

The pooled odds ratio for asthma diagnosis among cannabis users was 1.31 (95% CI: 1.19-1.44), indicating 31% greater odds compared to non-users.

Strong EvidenceMeta-Analysis

Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.

Velayudhan, Latha · 2024

THC alone and THC:CBD combinations significantly increased all-cause and treatment-related adverse events compared to controls.

Strong EvidenceMeta-Analysis

Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies

Theerasuwipakorn, Nonthikorn · 2023

As cannabis legalization expands globally, the cardiovascular safety question becomes increasingly urgent.

Strong EvidenceMeta-Analysis

A large-scale genome-wide association study meta-analysis of cannabis use disorder.

Johnson, Emma C · 2020

This GWAS meta-analysis identified 22 genome-wide significant loci associated with cannabis use disorder, with SNP-based heritability estimated at 11%.

Strong EvidenceMeta-Analysis

Genome-wide association meta-analysis of age at first cannabis use.

Minică, Camelia C · 2018

Researchers conducted the largest genome-wide association study of age at first cannabis use to date. Twin analysis (8,055 twins from three cohorts) estimated heritability at 38% (95% CI 19-60%).

Strong EvidenceMeta-Analysis

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.

Pasman, Joëlle A · 2018

In the largest GWAS of lifetime cannabis use to date, researchers analyzed 184,765 individuals and identified eight genome-wide significant SNPs in six genomic regions. All measured genetic variants combined explained 11% of the variance in cannabis use. Gene-based tests revealed 35 significant genes in 16 regions.